asa guidelines for glp 1 drugs Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Agonists Clinical Recommendations to Manage Gastrointestinal
Description
review, or approval of the manuscript
For higher-risk patients, the guidance suggests targeted mitigation strategies
Congressional Budget Office, which suggested the cost of the drugs could still exceed the savings from treating obesity and its attendant health conditions
In a patient on GLP1 receptor agonist therapy presenting with a severalhour headache, mild dehydration, and serum sodium of 128 mmol/L, could the headache and hyponatremia be caused by the GLP1 medication?
